Seminar - Scaling Risk Based Screening and Breast Cancer Prevention

Professor Graham Colditz, MD, DrPH

I will review our journey from identifying risk factors for breast cancer to models of risk prediction and image-based risk from screening mammograms that can more accurately classify level of risk for individual women. We must align screening and prevention strategies with individual risk to maximize the population benefits and reduce the burden of breast cancer.

Location: Seminar Room 515, Level 5, 207 Bouverie Street, Carlton VIC 3053 or via zoom https://unimelb.zoom.us/j/81850815241?pwd=JtChO8qPyZMexZVQ4vFRi4Zp78BwPe.1&from=addon

Meeting ID: 818 5081 5241, Password: 452603

Register on eventbrite: https://www.eventbrite.com.au/e/a-global-view-scaling-risk-based-screening-and-breast-cancer-prevention-tickets-1999241320608?aff=oddtdtcreator

Graham Colditz is the Niess-Gain Professor at Washington University School of Medicine and Associate Director for prevention and control at Siteman Cancer Center. He is highly cited for his research and has received numerous national awards for his contributions to cancer prevention. He is also the Co-Founder of Prognosia Inc, with Shu (Joy) Jiang. He has a long history of translating public health research to prevention and has developed a range of models integrating epidemiologic data to estimate risk and guide prevention. Your Disease Risk is one such tool https://siteman.washu.edu/prevention/ydr/ With Dr. Jiang he has focused on developing and applying AI technology for breast cancer risk prediction. Prognosia Breast has received the Breakthrough Device Designation from the FDA. The license for this software was acquired by Lunit (Volpara) in 2025.